Alpha Signal Monitor - Daily Market Briefing | April 15, 2026
Daily Market Research Report
April 15, 2026
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Institutional outlook on GLD/IAU/BAR (as proxies for spot gold) — compiled April 15, 2026
Trading Idea: Buy Rationale (TL;DR): Most top-tier houses (Goldman Sachs, JPMorgan, UBS, BofA, Deutsche Bank, HSBC) maintain bullish 2026 gold targets, with only Citi notably cautious; with central‑bank demand and easing real‑rate bias as tailwinds, we favor broad gold ETF exposure (GLD/IAU/BAR). (bloomberg.com)
After a sharp early‑2026 spike and subsequent volatility, banks still anchor on structural demand (central banks, diversification) and a softer policy backdrop into late‑2026; UBS CIO, for example, projects $5,900 by Dec‑26 after mid‑year peaks, while Goldman lifted its YE‑26 target to $5,400 citing persistent private and official‑sector buying. (ubs.com)
Key Drivers - Official‑sector (EM) gold accumulation and portfolio diversification (‘de‑dollarization’ narrative). (goldmansachs.com) - Falling or lower real yields into 2H‑26 as policy eases from restrictive levels. (ubs.com) - ETF participation alongside bar/coin demand on dips, aiding liquidity and price transmission. (mining.com) - Elevated fiscal deficits and macro/geopolitical risk premia supporting safe‑haven bids. (mining.com) - Range‑bound USD vs peers reduces a key headwind vs 2022–23 cycle. (ubs.com)
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Overweight/Bullish | Gold $5,400/oz by December 2026 (raised from $4,900). | GS cites continued private‑sector diversification atop strong central‑bank and ETF demand as justification for the upgrade. | January 22, 2026 | Bloomberg: Goldman Sachs raises year‑end 2026 gold target to $5,400. (bloomberg.com) |
| Morgan Stanley | Positive/Bullish | Gold $4,400/oz by end‑2026 (revised up from $3,313). | MS Research argues the rally should extend as central banks and ETFs buy into expected Fed cuts and a weaker USD; notes potential demand destruction if prices run too far, too fast. | October 22, 2025 | Morgan Stanley Insights: “Why Gold’s Rally Will Likely Go On.” (morganstanley.com) |
| JP Morgan | Overweight/Bullish | Gold to average ~$5,055/oz in Q4‑2026; multi‑year upside case to 2028 retained. | JPM Commodities Strategy calls gold its “highest conviction long,” assuming ~566t/quarter of combined investor + central‑bank demand in 2026. | October 24, 2025 | MINING.com summary of JPM note. (mining.com) |
| Bank of America | Overweight/Bullish | Gold $5,000/oz in 2026 (avg ~ $4,400). | BofA lifted 2026 outlook, citing deficits/debasement concerns and investment demand; also frames gold as a hedge alongside elevated AI‑led equity multiples. | October 13, 2025 | Reuters (mirrors): BofA hikes 2026 gold forecast to $5,000/oz. (tradingview.com) |
| Citigroup | Underweight/Cautious | Gold to $2,500–$2,700/oz by H2‑2026. | Citi expects investment demand to fade as growth confidence improves, projecting consolidation through 2025 and a retracement into late‑2026. | June 17, 2025 | Bloomberg/Reuters coverage: Citi calls time on gold’s rally; sees $2,500–$2,700 by H2‑26. (bloomberg.com) |
| UBS (CIO) | Overweight/Bullish | Gold $6,200/oz by Jun/Sep‑2026; $5,900 by Dec‑2026; $5,900 by Mar‑2027 (end‑period targets). | UBS CIO urges investors not to abandon gold’s hedge role despite volatility; expects macro support to reassert with lower yields and weaker USD later in 2026. | March 23, 2026 | UBS CIO View (PDF): “Don’t abandon the hedge” with explicit quarterly targets. (ubs.com) |
| HSBC | Positive/Bullish (peak risk flagged) | Gold could hit $5,000/oz in H1‑2026; trims 2026 average to ~$4,587; sees year‑end near $4,450. | HSBC highlights central‑bank demand, USD risks and ETF interest; also notes potential for a post‑peak correction later in 2026. | January 8, 2026 | Reuters (mirrors): HSBC expects $5,000 in H1‑2026; updated averages. (au.investing.com) |
| Deutsche Bank | Positive/Bullish | Gold $4,450/oz average in 2026 (range guided up to ~$4,950 peak in some reports). | DB raised 2026 forecast, citing resilient investor flows and persistent official‑sector buying. | November 26, 2025 | Reuters (mirrors): Deutsche Bank lifts 2026 forecast to $4,450/oz; supplementary coverage of peak range. (investing.com) |
Risk Considerations - Stronger‑for‑longer USD and/or higher real rates compress fair value and trigger ETF outflows. (ubs.com) - Sharp moderation in central‑bank purchases as prices rise could remove an important demand pillar. (mining.com) - Rapid de‑escalation of trade/geopolitical risks and firmer global growth could rotate flows out of gold (Citi’s base case for H2‑26 softness). (investing.com) - Liquidity shocks or margin hikes causing forced deleveraging, amplifying drawdowns. - Regulatory/tax changes on bullion/ETFs in key markets that impair demand.
Position via GLD/IAU/BAR as liquid spot‑gold proxies; lean into dips given consensus upside skew through late‑2026. For long‑only allocations, prefer cost‑efficient IAU/BAR; use GLD for maximum liquidity and options overlay flexibility. Stage entries to manage volatility around policy and geopolitics.
Stock Ratings — Street targets and ratings from GS, MS, JPM, BAC, C, WFC for selected megacaps (as of April 15, 2026)
Notes: Items reflect the most recent targets/rating changes we could verify from publicly accessible sources. Some broker research is paywalled; where no reliable public reference was found, fields are null. Consensus target is the simple average of available targets below; consensus rating is a qualitative read of available ratings.
AAPL - Apple Inc.
Broad coverage across the street; recent upside target revisions clustered around low-$300s.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs (高盛, GS) | Buy | $320 | 2026-02 | - | https://www.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-apple-stock-amid-recent-decline-93CH-4454913 |
| Morgan Stanley (大摩, MS) | Overweight | $315 | 2026-01 | MS raised PT from $305 to $315 per article summary. | https://finance.yahoo.com/news/morgan-stanley-lifts-apple-inc-133955780.html |
| JP Morgan (小摩, JPM) | Overweight | $315 | 2026-01-26 | Raised ahead of FYQ1-26 earnings per coverage summary. | https://macdailynews.com/2026/01/26/jpmorgan-boosts-apple-price-target-to-315-ahead-of-earnings-citing-strong-iphone-17-demand/ |
| Bank of America (美银, BAC) | Buy | $325 | 2026-04-14 | Raised PT to $325. | https://www.marketbeat.com/instant-alerts/bank-of-america-raises-apple-nasdaqaapl-price-target-to-32500-2026-04-14/ |
| Citigroup (花旗, C) | Buy | $330 | 2025-12 | - | https://finance.yahoo.com/news/apple-analyst-sets-bold-stock-040700179.html |
| Wells Fargo (富国银行, WFC) | - | - | - | - | - |
Consensus View - Rating: Buy, Target Price: $321 - Average of five available targets ($320, $315, $315, $325, $330).
MSFT - Microsoft Corp.
Banks remain constructive despite recent pullbacks tied to AI capex worries.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs (高盛, GS) | Buy | $480 | 2025-05 | Raised target; maintained Buy. | https://www.marketscreener.com/quote/stock/MICROSOFT-CORPORATION-4835/news/Microsoft-Goldman-Sachs-raises-target-price-49801559/ |
| Morgan Stanley (大摩, MS) | Overweight (Top Pick) | $650 | 2025-11 | - | https://www.investing.com/news/stock-market-news/morgan-stanley-on-microsoft-we-would-be-aggressive-buyers-on-any-pullbacks-4319100 |
| JP Morgan (小摩, JPM) | Overweight | $465 | 2025-02 | - | https://it.investing.com/news/analyst-ratings/jpmorgan-mantiene-il-rating-overweight-per-le-azioni-microsoft-con-un-target-di-465-93CH-2667637 |
| Bank of America (美银, BAC) | Buy | $500 | 2026-03-24 | Coverage reinstated with Buy and $500 PT. | https://api.finexus.net/api/news/events/fb885af7-08dc-4c50-977c-5a8bed7527a9/html |
| Citigroup (花旗, C) | Buy | $635 | 2026-01 | Cut to $635 from $660 after post-earnings move (per summary of broker actions). | https://capital.com/en-int/market-updates/microsoft-stock-forecast-17-02-2026 |
| Wells Fargo (富国银行, WFC) | Overweight | $675 | 2025-10-06 | Older call cited in roundup; included for completeness. | https://www.gurufocus.com/news/3172856/msft-sees-price-target-increase-to-690-by-citigroup-maintaining-buy-rating-msft-stock-news |
Consensus View - Rating: Buy, Target Price: $568 - Average of six available targets ($480, $650, $465, $500, $635, $675).
GOOGL - Alphabet Inc.
Targets vary with differing views on AI spend versus margin trajectory.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs (高盛, GS) | Buy | $400 | 2026-02 | Raised from $375. | https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/02/50409810/alphabet-earnings-review-goldman-sachs-analysis-price-target-google |
| Morgan Stanley (大摩, MS) | Overweight | $205 | 2025-08 | - | https://es.investing.com/news/analyst-ratings/morgan-stanley-eleva-el-precio-objetivo-de-las-acciones-de-alphabet-a-205-dolares-desde-185-dolares-93CH-3223605 |
| JP Morgan (小摩, JPM) | - | - | - | - | - |
| Bank of America (美银, BAC) | - | - | - | - | - |
| Citigroup (花旗, C) | - | - | - | - | - |
| Wells Fargo (富国银行, WFC) | Overweight | $387 | 2026-02-23 | Most recent PT cited in consensus trackers. | https://mlq.ai/stocks/GOOGL/price-target/ |
Consensus View - Rating: Buy, Target Price: $331 - Average of three available targets ($400, $205, $387).
AMZN - Amazon.com Inc.
Street remains positive, key debate is AWS margin/AI monetization pace.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs (高盛, GS) | Buy | $275 | 2025-10 | - | https://finance.yahoo.com/news/goldman-sachs-lifts-amazon-price-183530265.html |
| Morgan Stanley (大摩, MS) | Overweight (Top Pick) | $315 | 2025-12 | - | https://www.investing.com/news/stock-market-news/morgan-stanley-sees-40-upside-in-amazon-stock-on-aws-growth-potential-4369997 |
| JP Morgan (小摩, JPM) | - | - | - | - | - |
| Bank of America (美银, BAC) | Buy | $303 | 2026-03 | - | https://www.tipranks.com/news/bank-of-america-stays-bullish-on-amazon-stock-amzn-says-aws-ai-sentiment-key-driver-in-2026 |
| Citigroup (花旗, C) | - | - | - | - | - |
| Wells Fargo (富国银行, WFC) | Overweight | $305 | 2026-04-02 | Raised PT from $304 to $305. | https://www.gurufocus.com/news/8768432/amazon-amzn-maintained-as-overweight-by-wells-fargo-price-target-updated-amzn-stock-news |
Consensus View - Rating: Buy, Target Price: $300 - Average of four available targets ($275, $315, $303, $305).
NVDA - NVIDIA Corp.
Broadly bullish positioning; targets span mid-$200s on many lists post-GTC.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs (高盛, GS) | Buy | $240 | 2025-11 | Raised ahead of earnings. | https://finance.yahoo.com/news/goldman-sachs-expects-nvidia-beat-135658622.html |
| Morgan Stanley (大摩, MS) | Overweight | $260 | 2026-03-17 | Reiterated OW with $260 PT. | https://za.investing.com/news/analyst-ratings/morgan-stanley-reiterates-overweight-on-nvidia-stock-260-target-93CH-4168266 |
| JP Morgan (小摩, JPM) | - | - | - | - | - |
| Bank of America (美银, BAC) | Buy (Top Pick) | $275 | 2025-12 | - | https://finance.yahoo.com/news/bofa-reaffirms-ai-chip-giant-132830633.html |
| Citigroup (花旗, C) | - | - | - | - | - |
| Wells Fargo (富国银行, WFC) | Overweight | $265 | 2025-12 | - | https://finance.yahoo.com/news/nvidia-stock-rises-wells-fargo-132336478.html |
Consensus View - Rating: Buy, Target Price: $260 - Average of four available targets ($240, $260, $275, $265).
META - Meta Platforms Inc.
Citi and GS among the more bullish; WFC also positive historically.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs (高盛, GS) | Buy | $636 | 2026-03 | Raised from $555. | https://www.tipranks.com/news/the-fly/meta-platforms-price-target-raised-to-636-from-555-at-goldman-sachs |
| Morgan Stanley (大摩, MS) | - | - | - | - | - |
| JP Morgan (小摩, JPM) | - | - | - | - | - |
| Bank of America (美银, BAC) | - | - | - | - | - |
| Citigroup (花旗, C) | Buy | $690 | 2025-07 | - | https://www.investing.com/news/analyst-ratings/citi-raises-meta-platforms-price-target-to-690-on-strong-results-93CH-4015805 |
| Wells Fargo (富国银行, WFC) | - | - | - | - | - |
Consensus View - Rating: Buy, Target Price: $663 - Average of two available targets ($636, $690).
TSLA - Tesla Inc.
Divergent views: JPM notably bearish; MS and BAC more constructive.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs (高盛, GS) | - | - | - | - | - |
| Morgan Stanley (大摩, MS) | Overweight | $410 | 2025-03 | Cut from $430 to $410. | https://www.investing.com/news/analyst-ratings/morgan-stanley-cuts-tesla-stock-price-target-to-410-from-430-93CH-3940680 |
| JP Morgan (小摩, JPM) | Underweight | $145 | 2026-04-08 | Maintained $145 PT; reiterated bearish view. | https://finance.yahoo.com/markets/stocks/articles/tesla-could-crash-60-jpmorgan-184500211.html |
| Bank of America (美银, BAC) | Buy | $460 | 2026-03 | Coverage reinstated with $460 PT. | https://capital.com/en-int/market-updates/tesla-stock-forecast-11-03-2026 |
| Citigroup (花旗, C) | - | - | - | - | - |
| Wells Fargo (富国银行, WFC) | - | - | - | - | - |
Consensus View - Rating: Hold, Target Price: $338 - Mixed views; average of three available targets ($410, $145, $460).
AVGO - Broadcom Inc.
AI custom silicon and infrastructure software remain key drivers; several recent target hikes.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs (高盛, GS) | Buy | $435 | 2025-11 | - | https://www.gurufocus.com/news/3225513/goldman-sachs-raises-price-target-on-broadcom-avgo-to-435-reaffirms-buy-rating-avgo-stock-news |
| Morgan Stanley (大摩, MS) | Overweight | $470 | 2026-03 | Named top AI chip play vs. peers. | https://finance.yahoo.com/news/morgan-stanley-picks-broadcom-over-124709742.html |
| JP Morgan (小摩, JPM) | - | - | - | - | - |
| Bank of America (美银, BAC) | Buy | $500 | 2025-12 | Raised from $460. | https://finance.yahoo.com/news/bank-america-resets-broadcom-stock-213808046.html |
| Citigroup (花旗, C) | - | - | - | - | - |
| Wells Fargo (富国银行, WFC) | Overweight | $430 | 2026-01 | Upgraded to Overweight; PT raised. | https://www.investing.com/news/analyst-ratings/wells-fargo-upgrades-broadcom-stock-rating-on-ai-growth-potential-93CH-4449457 |
Consensus View - Rating: Buy, Target Price: $459 - Average of four available targets ($435, $470, $500, $430).
TSM - Taiwan Semiconductor Manufacturing Co., Ltd. (TSMC)
Most published targets for 2330.TW are in TWD; Citi recently lifted its local-currency PT materially on AI strength.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs (高盛, GS) | - | - | - | Recent articles note GS target lift but public sources did not show a specific figure. | https://finance.yahoo.com/news/goldman-sachs-lifts-tsmc-target-160700243.html |
| Morgan Stanley (大摩, MS) | - | - | - | Raised target per article summary; specific figure not disclosed in public snippet. | https://finance.yahoo.com/news/tsmc-stock-target-raised-morgan-121223698.html |
| JP Morgan (小摩, JPM) | - | - | - | - | - |
| Bank of America (美银, BAC) | - | - | - | - | - |
| Citigroup (花旗, C) | Buy | NT$2,800 | 2026-03 | Raised from NT$2,600. | https://www.investing.com/news/stock-market-news/tsmc-price-target-raised-at-citi-as-ai-megacycle-accelerates-4587255 |
| Wells Fargo (富国银行, WFC) | - | - | - | - | - |
Consensus View - Rating: Buy, Target Price: NT$2,800 - Only one verifiable bank target available in public domain; consensus mirrors Citi.
Highlights
- Apple (AAPL): BofA raised PT to $325 (Apr 14, 2026); GS, MS, JPM and Citi also positive in the low-$300s range.
- Microsoft (MSFT): MS keeps Top Pick with $650 PT; Citi $635; GS $480; BAC $500.
- NVIDIA (NVDA): BAC $275 (Top Pick), MS $260, GS $240, WFC $265 following GTC.
- Tesla (TSLA): JPM remains Underweight with $145 PT (Apr 2026), vs. MS $410 OW and BAC $460 Buy.
If you want every field fully populated with the absolute latest targets, please provide access to paywalled broker notes (Bloomberg/FactSet/Refinitiv/TipRanks/TheFly), or share your internal PDFs. I can then refresh all six institutions for each ticker and tighten dates/wording. As of April 15, 2026, entries above reflect the best-verified public summaries available.
IPO Calendar
Timeframe: April 15, 2026 to May 15, 2026 — U.S. equity markets
Issuance in the next 30 days is led by large industrial/defense offerings (Madison Air Solutions, Arxis, AEVEX) alongside selective biotech deals (Kailera Therapeutics, Salspera). Renaissance Capital notes these names on or near-term, with The Metals Royalty Co. completing a direct listing just before this window (April 8). Overall U.S. activity remains lighter than hoped, but the calendar is rebuilding with bigger, brand‑name industrials and late‑stage biotechs testing conditions. Dates and sizes remain subject to SEC effectiveness and market volatility. (renaissancecapital.com)
Madison Air Solutions Corporation (MAIR)
- Expected listing date: 2026-04-16
- Price range: $25.00–$27.00 per share (range set in roadshow launch)
- Shares offered: 82,692,308 primary shares (plus 30‑day over‑allotment option for underwriters)
- Exchange: NYSE
- Lead underwriters: Goldman Sachs & Co. LLC, Barclays, Jefferies, Wells Fargo Securities, BofA Securities, Citigroup, Baird, RBC Capital Markets, Guggenheim Securities, Santander, Wolfe | Nomura Alliance, CIBC Capital Markets, Comerica Securities, William Blair, Stifel, Capital One Securities, PNC Capital Markets
- Business summary: Portfolio owner of indoor air quality and air‑management brands (including Nortek Air Solutions, Nortek Data Center Cooling, AprilAire, Big Ass Fans) serving residential and commercial end‑markets such as data centers, semiconductor fabs, healthcare, and education; a significant portion of sales comes from replacement/upgrade and aftermarket, providing recurring revenue characteristics.
- Notes: Company launched its roadshow on April 6, 2026; intends to list on the NYSE under “MAIR” and to use net proceeds primarily to repay indebtedness. Renaissance Capital characterizes this as the largest U.S. IPO filed this year to date; expected to price the week of April 13, 2026. Timing subject to SEC effectiveness and market conditions.
- Sources: Company press release (roadshow launch), Renaissance Capital IPO News (terms and context), IPOX calendar (date), Reuters/Investing.com coverage of valuation and size
Arxis, Inc. (ARXS)
- Expected listing date: 2026-04-16 (expected)
- Price range: $25.00–$28.00 per share
- Shares offered: 37,735,849 shares (base deal)
- Exchange: Nasdaq Global Select Market
- Lead underwriters: Goldman Sachs & Co. LLC, Morgan Stanley, Jefferies, Citigroup, RBC Capital Markets, Baird, Guggenheim Securities, Wells Fargo Securities, William Blair, Rothschild & Co, Wolfe | Nomura Alliance, Citizens Capital Markets (co‑manager)
- Business summary: Designer and manufacturer of proprietary, mission‑critical electronic and mechanical engineered components used in aerospace and defense, medical technology, and specialized industrial markets; backed by Arcline Investment Management.
- Notes: Press release announces launch and terms; multiple calendars indicate an expected April 16, 2026 debut under “ARXS.” Filings and coverage highlight 2025 revenue of about $1.6 billion and net income of ~$46 million. Proceeds are expected to reduce leverage. Final timing and size remain subject to market conditions and SEC effectiveness.
- Sources: Company press release (launch; underwriters, range, ticker), Renaissance Capital IPO News (deal terms), IPOX calendar (expected date), Reuters/Bloomberg coverage of financials
AEVEX Corp. (AVEX)
- Expected listing date: 2026-04-17 (market calendars; pricing week of Apr 13)
- Price range: $18.00–$21.00 per share
- Shares offered: 16,000,000 shares (base deal) plus greenshoe (company and selling stockholder)
- Exchange: NYSE
- Lead underwriters: Goldman Sachs & Co. LLC, BofA Securities, Jefferies, J.P. Morgan, RBC Capital Markets, Baird, William Blair, Raymond James, Needham & Company, Academy Securities, Capital One Securities, PNC Capital Markets
- Business summary: Defense technology company focused on unmanned aircraft systems, loitering munitions, unmanned surface vessels, and mission solutions (ISR, aircraft modification/integration, intelligence analysis); U.S. government is the primary customer.
- Notes: Company launched its IPO roadshow on April 9, 2026 and applied to list on the NYSE as “AVEX.” Renaissance Capital reports terms ($18–$21; 16.0M shares) and indicates an expected pricing in the week of April 13, 2026; several calendars show April 17, 2026 as a tentative first trade date. Final date subject to SEC effectiveness and markets.
- Sources: Company press release (roadshow; range; ticker; underwriters), SEC Form S‑1/A (terms and details), Renaissance Capital IPO News (week‑ahead/terms), Market calendars (tentative date)
Kailera Therapeutics, Inc. (KLRA)
- Expected listing date: 2026-04-17 (expected)
- Price range: $14.00–$16.00 per share
- Shares offered: 33,333,334 shares (base deal); certain shareholders indicate $225 million of share purchases
- Exchange: Nasdaq Global Select Market
- Lead underwriters: J.P. Morgan, Jefferies, Leerink Partners, TD Securities, Evercore ISI
- Business summary: Phase 3 biotech developing injectable and oral GLP‑1‑based therapies for obesity; lead candidate ribupatide (weekly injectable) in global Phase 3, with an oral ribupatide tablet also in development.
- Notes: Renaissance Capital reports terms set April 13, 2026 and “expected to price this week”; IPO calendars show an expected April 17, 2026 debut under “KLRA.” As with all IPOs, timing depends on SEC effectiveness and market conditions.
- Sources: Renaissance Capital IPO News (terms, underwriters, timing), Fierce Biotech coverage (deal detail), IPOX calendar/StockAnalysis (expected date)
Salspera, Inc. (TKVA)
- Expected listing date: TBD (day‑to‑day; could fall in late April pending SEC effectiveness)
- Price range: $14.00–$16.00 per share (preliminary)
- Shares offered: 5,666,666 shares (base), plus 850,000 over‑allotment option
- Exchange: Nasdaq (application pending)
- Lead underwriters: Kingswood Capital Partners, LLC (sole book‑running manager)
- Business summary: Clinical‑stage immuno‑oncology company developing live‑biotherapeutic, orally administered Salmonella‑based treatments for solid tumors; lead program Saltikva (attenuated Salmonella engineered to express IL‑2) targeting metastatic pancreatic cancer and other solid tumors.
- Notes: Terms disclosed in March filings; issuer free‑writing prospectus and S‑1/A detail a $14–$16 range and the 5.67M‑share base deal. Fierce Biotech reports the company’s planned use of proceeds toward Phase 3 work. As of April 15, 2026, listing remains contingent on SEC effectiveness and market conditions.
- Sources: SEC Form S‑1/A (terms; ticker application), SEC FWP, Fierce Biotech (deal size/range and development context)
All dates, ranges, and share counts are subject to change until final prospectus/424B filings and official exchange notices. Micro‑cap and cross‑border issuers often price day‑to‑day; confirm latest filings before trading or allocation decisions. Primary sources used include issuer press releases, SEC EDGAR filings, and Renaissance Capital’s IPO News/Calendar; where calendars list tentative dates, this is reflected in notes.
Sources
- Stock Ratings: https://api.finexus.net/api/news/events/fb885af7-08dc-4c50-977c-5a8bed7527a9/html, https://capital.com/en-int/market-updates/microsoft-stock-forecast-17-02-2026, https://capital.com/en-int/market-updates/tesla-stock-forecast-11-03-2026, https://es.investing.com/news/analyst-ratings/morgan-stanley-eleva-el-precio-objetivo-de-las-acciones-de-alphabet-a-205-dolares-desde-185-dolares-93CH-3223605, https://finance.yahoo.com/markets/stocks/articles/tesla-could-crash-60-jpmorgan-184500211.html, https://finance.yahoo.com/news/apple-analyst-sets-bold-stock-040700179.html, https://finance.yahoo.com/news/bank-america-resets-broadcom-stock-213808046.html, https://finance.yahoo.com/news/bofa-reaffirms-ai-chip-giant-132830633.html, https://finance.yahoo.com/news/goldman-sachs-expects-nvidia-beat-135658622.html, https://finance.yahoo.com/news/goldman-sachs-lifts-amazon-price-183530265.html, https://finance.yahoo.com/news/goldman-sachs-lifts-tsmc-target-160700243.html, https://finance.yahoo.com/news/morgan-stanley-lifts-apple-inc-133955780.html, https://finance.yahoo.com/news/morgan-stanley-picks-broadcom-over-124709742.html, https://finance.yahoo.com/news/nvidia-stock-rises-wells-fargo-132336478.html, https://finance.yahoo.com/news/tsmc-stock-target-raised-morgan-121223698.html, https://it.investing.com/news/analyst-ratings/jpmorgan-mantiene-il-rating-overweight-per-le-azioni-microsoft-con-un-target-di-465-93CH-2667637, https://macdailynews.com/2026/01/26/jpmorgan-boosts-apple-price-target-to-315-ahead-of-earnings-citing-strong-iphone-17-demand/, https://mlq.ai/stocks/GOOGL/price-target/, https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/02/50409810/alphabet-earnings-review-goldman-sachs-analysis-price-target-google, https://www.gurufocus.com/news/3172856/msft-sees-price-target-increase-to-690-by-citigroup-maintaining-buy-rating-msft-stock-news, https://www.gurufocus.com/news/3225513/goldman-sachs-raises-price-target-on-broadcom-avgo-to-435-reaffirms-buy-rating-avgo-stock-news, https://www.gurufocus.com/news/8768432/amazon-amzn-maintained-as-overweight-by-wells-fargo-price-target-updated-amzn-stock-news, https://www.investing.com/news/analyst-ratings/citi-raises-meta-platforms-price-target-to-690-on-strong-results-93CH-4015805, https://www.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-apple-stock-amid-recent-decline-93CH-4454913, https://www.investing.com/news/analyst-ratings/morgan-stanley-cuts-tesla-stock-price-target-to-410-from-430-93CH-3940680, https://www.investing.com/news/analyst-ratings/wells-fargo-upgrades-broadcom-stock-rating-on-ai-growth-potential-93CH-4449457, https://www.investing.com/news/stock-market-news/morgan-stanley-on-microsoft-we-would-be-aggressive-buyers-on-any-pullbacks-4319100, https://www.investing.com/news/stock-market-news/morgan-stanley-sees-40-upside-in-amazon-stock-on-aws-growth-potential-4369997, https://www.investing.com/news/stock-market-news/tsmc-price-target-raised-at-citi-as-ai-megacycle-accelerates-4587255, https://www.marketbeat.com/instant-alerts/bank-of-america-raises-apple-nasdaqaapl-price-target-to-32500-2026-04-14/, https://www.marketscreener.com/quote/stock/MICROSOFT-CORPORATION-4835/news/Microsoft-Goldman-Sachs-raises-target-price-49801559/, https://www.tipranks.com/news/bank-of-america-stays-bullish-on-amazon-stock-amzn-says-aws-ai-sentiment-key-driver-in-2026, https://www.tipranks.com/news/the-fly/meta-platforms-price-target-raised-to-636-from-555-at-goldman-sachs, https://za.investing.com/news/analyst-ratings/morgan-stanley-reiterates-overweight-on-nvidia-stock-260-target-93CH-4168266
- IPO Calendar: https://www.renaissancecapital.com/IPO-Center/News/118069/US-IPO-Week-Ahead-Critical-metals-direct-listing-on-the-calendar?utm_source=openai
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2026-04-15 at 11:44 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI